Search results
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries.
A multi-institutional effort to enable big data analytics and integrative genomics in Singapore, named the Centre for Big Data and Integrative Genomics (c-BIG), is at the core of GIS. It enables high throughput sequencing, molecular cytogenetics, bioinformatics, single-cell genomics, high throughput / content screening and genome engineering.
QIAGEN‘s contributions and products are expanding the frontiers of science and healthcare every day and set standards in markets for Molecular Diagnostic, Applied Testing, Pharma and Academic Research, for purposes such as forensics, animal or food testing and pharma process control.
13 QIAGEN reviews in Singapore. A free inside look at company reviews and salaries posted anonymously by employees.
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample...
Feb 7, 2024 · With the introduction of new syndromic testing for central nervous system infections, QIAGEN expands its QIAstat-Dx syndromic testing menu, complementing it with QIAstat-Dx Respiratory SARS-CoV-2 Panel and QIAstat-Dx Gastrointestinal Panel in Singapore.
This office is the major QIAGEN Singapore, Singapore area location. Find the QIAGEN Singapore address. Browse jobs and read about the QIAGEN Singapore location with content posted anonymously by QIAGEN employees in Singapore, Singapore.
Glassdoor has 893 QIAGEN reviews submitted anonymously by QIAGEN employees. Read employee reviews and ratings on Glassdoor to decide if QIAGEN is right for you.
Feb 7, 2024 · QIAGEN's QIAstat-DxMeningitis/Encephalitis Panel, a qualitative multiplexed nucleic acid-based in vitro diagnostic test has received approval from the Health Sciences Authority Singapore (HSA).
